Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease

Area of Science:

• Immunology
• Virology
• Pathophysiology

Background:

• Severe coronavirus disease 2019 (COVID-19) is linked to multi-organ dysfunction, high morbidity, and mortality.
• Maladaptive over-activation of innate immune pathways, particularly the complement cascade, and endothelial dysfunction are implicated in COVID-19 progression.

Purpose of the Study:

• To review the complement pathways involved in severe COVID-19.
• To examine the effects of SARS-CoV-2 on these immune pathways.
• To identify promising therapeutic targets for clinical trials.

Main Methods:

• Literature review of complement pathways.
• Analysis of SARS-CoV-2 interactions with immune systems.
• Survey of ongoing clinical trials for COVID-19 therapeutics.

Main Results:

• The complement cascade plays a critical role in the pathophysiology of severe COVID-19.
• SARS-CoV-2 infection can trigger and dysregulate complement activation.
• Endothelial dysfunction is a key consequence of these immune responses.

Conclusions:

• Understanding complement activation and endothelial dysfunction is crucial for managing severe COVID-19.
• Targeting these pathways offers potential therapeutic strategies.
• Clinical trials are investigating novel treatments for COVID-19 based on these findings.